Patent number: 10413587
Histatin for corneal wound healing and ocular surface disease
Original Assignee: Rapid Pathogen Screening, Inc.
Field of technology: Biotech, Medical
Patent granted on: Tue, 17 Sep 2019
Abstract
Histatins may be used for corneal wound healing and as a treatment for ocular surface disease in humans and other animals. For example, histatins could be included in eye drops, eye gels, ointment, glue, or embedded in (polymer) contact lenses.